Spider Rock Advisors, LLC Gilead Sciences, Inc. Put Options Transaction History

Spider Rock Advisors, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $115,744 - $134,400	-1,600 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $50,104 - $64,176	800 Added 100.0%	1,600 $4,000
Q4 2019 Jan 17, 2020	BUY	$61.62 - $67.78 $49,296 - $54,224	800 New	800 $2,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $377,095 - $442,656	-5,300 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$72.11 - $85.47 $382,183 - $452,991	5,300	5,300 $3,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spider Rock Advisors, LLC with notifications on news.